Results 81 to 90 of about 158,510 (246)
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
Critical Care, 2020 Background COVID-19-related ARDS has unique features when compared with ARDS from other origins, suggesting a distinctive inflammatory pathogenesis. Data regarding the host response within the lung are sparse.
M. Blot +25 more
semanticscholar +1 more source
Critical Care, 2019 BackgroundPosttraumatic stress disorder (PTSD) symptoms are common in acute respiratory distress syndrome (ARDS) survivors. Brief screening instruments are needed for clinical and research purposes.
M. Hosey +10 more
semanticscholar +1 more source
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
Stem cell research & therapeutics, 2020 Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate. Survivors usually have low quality of life. Current clinical management strategies are respiratory support and restricted fluid input, and there is no suggested ...
K. Xiao +5 more
semanticscholar +1 more source
Medical Management and Nursing Care of a Patient with Acute Respiratory Distress Syndrome
Bezmiâlem Science, 2022 Acute respiratory distress syndrome (ARDS) is a critical, life-threatening condition involving both lungs, characterized by capillary endothelial damage, diffuse pulmonary infiltration, and oxygen-resistant hypoxemia.
Rukiye Pınar BÖLÜKTAŞ +2 more
doaj +1 more source
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
Intensive Care Medicine, 2020 ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and repair, and
S. Horie +11 more
semanticscholar +1 more source
COVID-19, Chronic Obstructive Pulmonary Disease and Pneumothorax: A Frightening Triad
European Journal of Case Reports in Internal Medicine, 2020 We describe the case of a male patient admitted to our emergency department during the Italian COVID-19 epidemic, for progressive worsening dyspnoea.
Erika Poggiali +5 more
doaj +1 more source
Missed or delayed diagnosis of ARDS: a common and serious problem
Intensive Care Medicine, 2020 Clinical recognition of acute respiratory distress syndrome (ARDS) is delayed or missed entirely in a substantial proportion of patients. In the LUNG SAFE study, the largest international cohort of patients with ARDS, investigators were able to determine
G. Bellani, T. Pham, J. Laffey
semanticscholar +1 more source
Current and evolving standards of care for patients with ARDS
Intensive Care Medicine, 2020 Care for patients with acute respiratory distress syndrome (ARDS) has changed considerably over the 50 years since its original description. Indeed, standards of care continue to evolve as does how this clinical entity is defined and how patients are ...
M. Menk +9 more
semanticscholar +1 more source
Metabolic signatures of ARDS and ARDS heterogeneity [PDF]
American Journal of Physiology-Lung Cellular and Molecular Physiology, 2021 Lucile Neyton, Carolyn S. Calfee
openaire +3 more sources
Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients
Open Medicine, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is now a serious public health problem. Angiotensin-converting enzyme 2 (ACE2) recognized as the receptor of SARS-CoV is also necessary for SARS-CoV-2.
Ren Peng, Gong Caifeng, Ma Shaohua
doaj +1 more source